{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:12:32Z","timestamp":1781835152289,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T00:00:00Z","timestamp":1619913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017645","name":"Moorfields Eye Charity","doi-asserted-by":"publisher","award":["166186"],"award-info":[{"award-number":["166186"]}],"id":[{"id":"10.13039\/501100017645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000367","name":"British Council for Prevention of Blindness","doi-asserted-by":"publisher","award":["165223"],"award-info":[{"award-number":["165223"]}],"id":[{"id":"10.13039\/501100000367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870655"],"award-info":[{"award-number":["81870655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ajo.2021.04.020","type":"journal-article","created":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T09:46:09Z","timestamp":1619948769000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China \u2013 A Randomized Controlled Trial: Design and Baseline Characteristics"],"prefix":"10.1016","volume":"230","author":[{"given":"Yangfan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1527-6803","authenticated-orcid":false,"given":"Yuzhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Nathwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-0767","authenticated-orcid":false,"given":"Xiulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus","family":"Gazzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minbin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2021.04.020_bib0001","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2021.04.020_bib0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","article-title":"Number of people with glaucoma worldwide","volume":"80","author":"Quigley","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.04.020_bib0003","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.survophthal.2013.09.003","article-title":"Population-based glaucoma prevalence studies in Asians","volume":"59","author":"Cho","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2021.04.020_bib0004","article-title":"National and subnational prevalence and burden of glaucoma in China: A systematic analysis","volume":"7","author":"Song","year":"2017","journal-title":"J Glob Health"},{"issue":"6","key":"10.1016\/j.ajo.2021.04.020_bib0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ajo.2010.06.037","article-title":"Prevalence of glaucoma in North China: the Beijing Eye Study","volume":"150","author":"Wang","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2021.04.020_bib0006","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1167\/iovs.06-0051","article-title":"Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District","volume":"47","author":"He","year":"2006","journal-title":"Guangzhou. Invest Ophthalmol Vis Sci."},{"issue":"11","key":"10.1016\/j.ajo.2021.04.020_bib0007","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1167\/iovs.11-7472","article-title":"Handan Eye Study Group. Prevalence of primary open angle glaucoma in a rural adult Chinese population: the Handan eye study","volume":"52","author":"Liang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.04.020_bib0008","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12886-015-0124-x","article-title":"Prevalence and risk factors of primary open-angle glaucoma in a city of Eastern China: a population-based study in Pudong New District, Shanghai","volume":"15","author":"He","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2021.04.020_bib0009","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1442-9071.2011.02530.x","article-title":"Economic impact of primary open-angle glaucoma in Australia","volume":"39","author":"Dirani","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.04.020_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0266462399015299","article-title":"Modeling cost of treatment with new topical treatments for glaucoma. Results from France and the United Kingdom","volume":"15","author":"Kobelt","year":"1999","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"10.1016\/j.ajo.2021.04.020_bib0011","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0008-4182(06)80006-2","article-title":"Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan","volume":"41","author":"Lee","year":"2006","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2021.04.020_bib0012","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1185\/03007990802379996","article-title":"Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US","volume":"24","author":"Cantor","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.ajo.2021.04.020_bib0013","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ophtha.2008.12.056","article-title":"The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States","volume":"116","author":"Rein","year":"2009","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2021.04.020_bib0014","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bjophthalmol-2017-310877","article-title":"LiGHT Trial Study Group. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology","volume":"102","author":"Gazzard","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2021.04.020_bib0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bjophthalmol-2017-310870","article-title":"LiGHT Trial Study Group. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics","volume":"102","author":"Konstantakopoulou","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"10180","key":"10.1016\/j.ajo.2021.04.020_bib0016","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"LiGHT Trial Study Group. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"issue":"10180","key":"10.1016\/j.ajo.2021.04.020_bib0017","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(18)32553-4","article-title":"Laser trabeculoplasty as first-line glaucoma treatment","volume":"393","author":"Young","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajo.2021.04.020_bib0018","first-page":"97","article-title":"Selective laser trabeculoplasty:up-to-date choice for glaucoma treatment","volume":"32","author":"Sun","year":"2014","journal-title":"Zhonghua Shiyan Yanke Zazhi\/Chinese Journal of Experimental Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.04.020_bib0019","first-page":"159","article-title":"Multicenter clinical study of safety and efficacy of selective laser trabeculoplasty for Chinese primary open angle glaucoma","volume":"32","author":"Ge","year":"2014","journal-title":"Zhonghua Shiyan Yanke Zazhi\/Chinese Journal of Experimental Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.04.020_bib0020","first-page":"109","article-title":"A prospective randomized study of selective laser trabeculoplasty (SLT) as a replacement for medical therapy in primary open-angle glaucoma","volume":"51","author":"Zhang","year":"2015","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"10","key":"10.1016\/j.ajo.2021.04.020_bib0021","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/IJG.0000000000001018","article-title":"West Indies Glaucoma Laser Study (WIGLS)-2: Predictors of Selective Laser Trabeculoplasty Efficacy in Afro-Caribbeans With Glaucoma","volume":"27","author":"Realini","year":"2018","journal-title":"J Glaucoma"},{"issue":"4","key":"10.1016\/j.ajo.2021.04.020_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/aos.13949","article-title":"Comparison between 90-degree and 360-degree selective laser trabeculoplasty (SLT): A 2-year follow-up","volume":"97","author":"Tawfique","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2021.04.020_bib0023","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/aos.14067","article-title":"Evaluation of selective laser trabeculoplasty as an intraocular pressure lowering option","volume":"97","author":"Belitsky","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.04.020_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamaophthalmol.2013.1706","article-title":"Selective laser trabeculoplasty for the management of open-angle glaucoma in St. Lucia","volume":"131","author":"Realini","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.04.020_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jfo.2018.02.018","article-title":"Trab\u00e9culoplastie s\u00e9lective chez le m\u00e9lanoderme africain [Selective laser trabeculoplasty in African blacks]","volume":"42","author":"Ouattara","year":"2019","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.ajo.2021.04.020_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7620706","article-title":"Efficacy and Safety of Selective Laser Trabeculoplasty among Ethiopian Glaucoma Patients","volume":"2020","author":"Soboka","year":"2020","journal-title":"J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.04.020_bib0027","first-page":"742","article-title":"Selective laser trabeculoplasty","volume":"5","author":"Shi","year":"2012","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.04.020_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/IJG.0b013e3182027596","article-title":"Selective laser trabeculoplasty in the treatment of open-angle glaucoma","volume":"21","author":"Koucheki","year":"2012","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2021.04.020_bib0029","series-title":"Glaucoma: diagnosis and management. London: National Institute for Health and Care Excellence (UK)","year":"2017"},{"issue":"5","key":"10.1016\/j.ajo.2021.04.020_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.002","article-title":"4th Edition - Chapter 2: Classification and terminology Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology","volume":"101","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.04.020_bib0031","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","article-title":"Estimating an EQ-5D-5L Value Set for China","volume":"20","author":"Luo","year":"2017","journal-title":"Value Health."},{"issue":"1","key":"10.1016\/j.ajo.2021.04.020_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: An EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"9","key":"10.1016\/j.ajo.2021.04.020_bib0033","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0161-6420(02)01167-3","article-title":"European Glaucoma Prevention Study Group. The European glaucoma prevention study design and baseline description of the participants","volume":"109","author":"Miglior","year":"2002","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2021.04.020_bib0034","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.ophtha.2013.07.054","article-title":"United Kingdom Glaucoma Treatment Study Group. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics","volume":"120","author":"Lascaratos","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2021.04.020_bib0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":"The Ocular Hypertension Treatment Study: design and baseline description of the participants","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"9774","key":"10.1016\/j.ajo.2021.04.020_bib0036","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"Glaucoma","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ajo.2021.04.020_bib0037","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.04.020_bib0038","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: the Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2021.04.020_bib0039","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0161-6420(96)30449-1","article-title":"Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study","volume":"103","author":"Mitchell","year":"1996","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2021.04.020_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.APO.0000605096.48529.9c","article-title":"Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management","volume":"8","author":"Lee","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ajo.2021.04.020_bib0041","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2018.10.017","article-title":"Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis","volume":"199","author":"Zhao","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2021.04.020_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111879","article-title":"Age-related association of refractive error with intraocular pressure in the Korea National Health and Nutrition Examination Survey","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajo.2021.04.020_bib0043","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","article-title":"Canadian EQ-5D-5L Valuation Study Group. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada","volume":"54","author":"Xie","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.ajo.2021.04.020_bib0044","first-page":"47","article-title":"Developing a Japanese version of the EQ-5D-5L value set","volume":"64","author":"Ikeda","year":"2015","journal-title":"J Natl Inst Public Health"},{"issue":"7","key":"10.1016\/j.ajo.2021.04.020_bib0045","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","article-title":"The EQ-5D-5L valuation study in Korea","volume":"25","author":"Kim","year":"2016","journal-title":"Qual Life Res"},{"issue":"10","key":"10.1016\/j.ajo.2021.04.020_bib0046","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jclinepi.2015.04.011","article-title":"Interpretation and use of the 5-level EQ-5D response labels varied with survey language among Asians in Singapore","volume":"68","author":"Luo","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.ajo.2021.04.020_bib0047","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s11136-017-1541-5","article-title":"An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D","volume":"26","author":"Feng","year":"2017","journal-title":"Qual Life Res"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:47:40Z","timestamp":1757598460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":47,"alternative-id":["S0002939421002191"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.04.020","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China \u2013 A Randomized Controlled Trial: Design and Baseline Characteristics","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}